抑郁症多基因负荷与多发性硬化疾病活动及残疾恶化的关联
该队列研究纳入3420例欧洲遗传 ancestry 的复发型多发性硬化患者,计算抑郁症多基因评分(PGS),分析其与年化复发率及残疾恶化的关联。荟萃分析显示,抑郁症PGS每增加1个标准差,复发率增加(IRR=1.23,95%CI=1.01-1.50)。美国队列中,较高抑郁症PGS与方案定义的复发(HR=1.58,95%CI=1.03-2.43)及确认的EDSS恶化时间(HR=1.51,95%CI=1.03-2.22)相关。
要点
- 抑郁症多基因负荷较高与MS复发率增加相关(IRR=1.23)。
- 美国队列中,较高抑郁症PGS与复发风险及EDSS恶化风险增加相关。
- 抑郁症遗传负担可能为MS疾病活动提供线索。
核心结论
- 荟萃分析显示较高的抑郁症遗传负担与多发性硬化疾病活动增加相关。
- 仅在美国临床试验队列中,较高抑郁症PGS与复发时间及确认的EDSS恶化时间显著相关,效应 largely direct。
研究设计与样本
- 队列研究,使用来自加拿大、美国、瑞典现有队列的神经科医生定义的成人多发性硬化患者样本,随访于临床诊疗或临床试验中,具有广泛纵向表型。
- 纳入3420例欧洲遗传 ancestry 的复发型多发性硬化患者,中位随访3至5年。
- 计算抑郁症多基因评分(PGS),检验其与年化复发率和残疾恶化的关联;美国队列额外探索复发时间、强化病灶数目及研究期间确认的EDSS恶化。
主要发现
- 荟萃分析显示,抑郁症PGS每增加1个标准差,复发率增加(IRR=1.23,95%CI=1.01-1.50)。
- 美国队列中,较高抑郁症PGS与方案定义的复发相关(HR=1.58,95%CI=1.03-2.43)。
- 美国队列中,较高抑郁症PGS与确认的EDSS恶化时间相关(HR=1.51,95%CI=1.03-2.22),效应 largely direct。
临床怎么用
- 在MS患者中评估抑郁症遗传负荷可能有助于识别疾病活动及残疾恶化风险较高的个体。
- 但当前证据主要来自欧洲遗传 ancestry 人群,临床应用中需结合其他临床因素综合判断。
局限性
- 研究仅纳入欧洲遗传 ancestry 的复发型MS患者,结果外推至其他人群需谨慎。
- 美国队列中复发时间及EDSS恶化的关联仅在临床试验队列中显著,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A better understanding of factors associated with multiple sclerosis (MS) disease activity and disability is needed. Given the strong link between comorbid depression and MS disease activity and disability, we aimed to determine whether the depression genetic burden, as modelled using its polygenic score, is associated with MS disease activity and disability worsening. METHODS: In this cohort study, we used samples from neurologist-defined adult people with MS (PwMS) followed in clinical care or during a clinical trial from existing cohorts: Canada, the United States (US), and Sweden with extensive longitudinal phenotypes. We computed the depression polygenic score (PGS) and tested its association with annualized relapse rate and worsening disability. In the US cohort, we additionally explored the time to relapse, number of enhancing lesions, and confirmed Expanded Disability Status Scale (EDSS) worsening during the study period. RESULTS: We included 3,420 relapsing-onset PwMS of European genetic ancestry with a median follow-up of 3 to 5 years. Meta-analyses revealed for each 1-standard deviation increase in the depression PGS, the relapse rate increased (incidence rate ratio: 1.23, 95% confidence interval [CI] = 1.01-1.50). In the US cohort, higher depression PGS was associated with protocol-defined relapses (hazard ratio [HR] = 1.58, 95% CI = 1.03-2.43), and time to confirmed EDSS worsening (HR = 1.51, 95% CI = 1.03-2.22) with this effect largely direct. INTERPRETATION: Meta-analyses showed a higher depression genetic burden was associated with increased MS disease activity. In the US clinical trial cohort only, we found a significant association between higher depression PGS and time to relapse and confirmed EDSS worsening. These findings may provide insights into MS disease activity and disability worsening. ANN NEUROL 2025;98:1057-1069.
引用
- Manouchehrinia A, Fitzgerald KC, Salter A, et al. Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis. Ann Neurol. 2025. PMID: 40772555. doi:10.1002/ana.70020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。